(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the eve of Governor Andrew Cuomo’s 2020 State of the State Address and the start of the state legislative session in Albany:
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott joined other organization and company CEOs to sign the CEO Action Pledge supporting more diversity and inclusion within the workplace. The CEO pledge outlines a specific set of actions
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following response to this morning’s remarks by Food and Drug Administration (FDA) Commissioner Scott Gottlieb: “In an era of rising drug prices, employers, insurers and other payers have an
“Frozen formulary” legislation refers to regulations proposed by state legislators that would prohibit a pharmacy benefit manager (PBM) or health plan from making certain changes to a prescription formulary midyear. Based on a recent analysis, Milliman estimates the proposed “frozen formulary”
The PCMA says in a statement it supports the patient always paying the lowest cost at the pharmacy counter, whether the cash price or the copay
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s vote in the Energy and Commerce Subcommittee on Health on the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act:
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on bipartisan Senate companion legislation (Every Prescription Conveyed Securely Act) to combat opioid abuse through the increased use of electronic prescribing (e-prescribing) in Medicare Part D, introduced
Pennsylvania has proposed legislation (PA HB 941) to reconfigure the payment rates used for Medicaid prescriptions paid by Medicaid MCOs to pharmacies. This study conveys findings from our efforts to reprice Pennsylvania’s 2018 Medicaid MCO prescription drug claims to estimate
(Washington, D.C.) — In response to litigation brought by the Pharmaceutical Care Management Association (PCMA) challenging the Medicare Part D rebate rule, the Biden Administration agreed to postpone the effective date of the provisions of the rule relating to the elimination
(Washington, D.C.) — Senior registered voters enrolled in Medicare Part D will be less likely to support the reelection of their members of Congress and presidential candidates if those elected officials back proposals eliminating prescription drug negotiations and price concessions
©2024 PCMA. All Rights Reserved.
